What can we expect?

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

What can we expect?

posted on Jul 22, 2010 09:37AM

You don't have to have business experience, common sense does it also to recognize how things proceed in the normal world:

1. The company can only annouce something if they have it in written form = the letter of the NIRC has to be on the desk of PTSC/TPL.

2. Even if dozen of companies were only waiting to purchase a license if/when the USPTO revalidates the patent it takes time to finalize the agreement - provided the responsible persons are not on vacation (which could delay things).

3. As we all know the recert for the '336 is great, but only as long as the sales channel is working 100% = the TPL/CM/PTSC partnership is re-installed (they all want to make money thus a solution should be achievable). So far we don't know what happened here, but there is a good chance the partnership will be more favourable for us in the future.

4. Anouncing new partners for PDSG is a great sign = PDSG probably won't be sold in the near future - but it doesn't mean revenues are around the corner, PDSG is still a start-up (without a CEO btw).

5. As some have pointed out PTSC/TPL need a huge court victory - let's hope the current T3 litigation leads to this result, but probably not before 2011.

In a nutshell: Though I'd like the SP to explode immediately we have to be realistic about the next and necessary steps to increase revenues (which is the only thing that counts for shareholder value and therefore positive SP development).